Functionally, Tollip and Bcl10 are linked to the regulation of pro-inflammatory responses through the activation of NF-κB, a transcription factor that is pro-tumorigenic and a prime target in human cancer [34,35,36]. This evidence concerns the gene BCL10 and cancer.